Diagnostic Photoacoustic Imaging

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Optical Diagnostics".

Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 4659

Special Issue Editor


E-Mail
Guest Editor
Pennsylvania State University, University Park, TX, USA
Interests: photoacoustic imaging; molecular imaging; ultrasound; machine and deep learning; cancer; neuroscience; cardiovascular; wearable sensing

Special Issue Information

Dear Colleagues,

Photoacoustic imaging (PAI) gained significant attention from the biomedical community by displaying rich optical contrast information of deep biological tissue with high spatial resolution. For example, the optical absorption of hemoglobin molecules allows PAI to generate label-free images of blood vasculature, associated functional oxygen saturation, blood flow, and blood volume. Such multiparametric vascular information alone has attracted several pre-clinical and clinical applications in diagnosing vascular diseases, cancer detection, tissue metabolism, and monitoring brain activity. Further molecular imaging strategies using contrast agents have been developed to improve the sensitivity and specificity of PAI for disease detection. Since ultrasound and PAI share the same detection platform, conventional ultrasound systems can be easily adapted to display dual-modality anatomical ultrasound and functional/molecular photoacoustic information of the deep tissue. Like ultrasound, PAI systems are non-ionizing, non-invasive, portable, low-cost, and can be realized in various form factors to suit different clinical applications. This includes photoacoustic microscopy (PAM) for imaging superficial tissue depths with micron-scale spatial resolution, photoacoustic endoscopy (PAE) for imaging internal organs at scalable spatial resolution and imaging depth, and photoacoustic tomography (PAT) for deep tissue imaging with ultrasonic spatial resolution. In recent years, PAI has been translated to clinical applications such as cancer detection of breast, prostate, and ovaries; imaging primary melanoma and melanoma metastasis; detecting circulating melanoma tumor cells, monitoring Chron’s disease activity, arthritis, muscular dystrophy, and tissue metabolism. This Special Issue encompasses a broad range of such emerging clinical applications of PAI, including wearable and point-of-care imaging, and the role of machine- and deep learning-based artificial intelligence for further enhancing the performance of PAI in the clinic.

Dr. Sri-Rajasekhar Kothapalli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Early detection and monitoring of cancer, arthritis, metabolic, vascular, and neuro diseases
  • Molecular imaging strategies with immediate potential for clinical translation
  • Image-guided surgeries
  • Neonatal brain imaging
  • Point-of-care sensing or imaging
  • Machine and deep learning methods
  • Low-cost diagnostic PAI systems integrating components such as light-emitting diodes, laser diodes, and ultrasound devices, and miniaturized scanners
  • Durable and stable phantoms for routine clinical validation
  • Image reconstruction and signal processing algorithms
  • Novel multimodal systems integrating PAI (e.g., combined PAI and fluorescence imaging device)

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 5327 KiB  
Article
Acute Radiation Dermatitis Evaluation with Reflectance Confocal Microscopy: A Prospective Study
by Juras Kišonas, Jonas Venius, Mindaugas Grybauskas, Daiva Dabkevičienė, Arvydas Burneckis and Ričardas Rotomskis
Diagnostics 2021, 11(9), 1670; https://doi.org/10.3390/diagnostics11091670 - 13 Sep 2021
Cited by 3 | Viewed by 1796
Abstract
Background: During radiotherapy (RT), most breast cancer patients experience ionizing radiation (IR)-induced skin injury—acute radiation dermatitis (ARD). The severity of ARD is determined by a physician according to CTCAE or RTOG scales, which are subjective. Reflectance confocal microscopy (RCM) is a noninvasive skin [...] Read more.
Background: During radiotherapy (RT), most breast cancer patients experience ionizing radiation (IR)-induced skin injury—acute radiation dermatitis (ARD). The severity of ARD is determined by a physician according to CTCAE or RTOG scales, which are subjective. Reflectance confocal microscopy (RCM) is a noninvasive skin imaging technique offering cellular resolution. Digital dermoscopy (DD) performed in conjugation with RCM can provide more information regarding skin toxicity. The purpose of this study is to create an RCM and DD features-based ARD assessment scale, to assess the association with CTCAE scale and possible predictive value. Methods: One hundred and three breast cancer patients during RT were recruited; every week, clinical symptoms of ARD (CTCAE scale) were evaluated and RCM, together with digital dermoscopy (DD), was performed. Results: According to RCM; after 2 RT weeks, exocytosis and/or spongiosis were present in 94% of patients; after 3 weeks, mild contrast cells (MMCs) were detected in 45%; disarrayed epidermis (DE) was present in 66% of patients after 4 weeks and in 93% after 5 weeks; abnormal dermal papillae (ADP) were present in 68% of patients after 5 weeks. The coefficients of RCM features (RCMcoef) alone and together with dermoscopically determined erythema (RCM-ERYcoef) were significantly associated with ARD severity grade. RCMcoef is a significant predictive factor for the clinical manifestation of ARD. Conclusions: RCM features of irradiated skin appear earlier than clinical symptoms, have a characteristic course, and allow the severity of ARD to be predicted. Full article
(This article belongs to the Special Issue Diagnostic Photoacoustic Imaging)
Show Figures

Figure 1

11 pages, 1164 KiB  
Article
Polymer-Peptide Modified Gold Nanorods to Improve Cell Conjugation and Cell Labelling for Stem Cells Photoacoustic Imaging
by Dina Salah, Farahat S. Moghanm, Muhammad Arshad, Abdulaziz A. Alanazi, Salman Latif, Maie I. El-Gammal, Elmahdy M. Shimaa and Salah Elsayed
Diagnostics 2021, 11(7), 1196; https://doi.org/10.3390/diagnostics11071196 - 30 Jun 2021
Cited by 7 | Viewed by 2407
Abstract
The use of gold nanorods (GNRs) as a contrast agent in bioimaging and cell tracking has numerous advantages, primarily due to the unique optical properties of gold nanorods which allow for the use of infrared regions when imaging. Owing to their unique geometry, [...] Read more.
The use of gold nanorods (GNRs) as a contrast agent in bioimaging and cell tracking has numerous advantages, primarily due to the unique optical properties of gold nanorods which allow for the use of infrared regions when imaging. Owing to their unique geometry, Au NRs exhibit surface plasmon modes in the near-infrared wavelength range, which is ideal for carrying out optical measurements in biological fluids and tissue. Gold nanorod functionalization is essential, since the Cetyltrimethyl ammonium bromide CTAB gold nanorods are toxic, and for further in vitro and in vivo experiments the nanorods should be functionalized to become optically stable and biocompatible. In the present study, gold nanorods with an longitudinal surface plasmon resonance (LSPR) position around 800 nm were synthesized in order to be used for photoacoustic imaging applications for stem cell tracking. The gold nanorods were functionalized using both thiolated poly (ethylene glycol) (PEG) to stabilize the gold nanorods surface and a CALNN–TAT peptide sequence. Both ligands were attached to the gold nanorods through an Au–sulfur bond. CALNN–TAT is known as a cell penetrating peptide which ensures endocytosis of the gold nanorods inside the mesenchymal stem cells of mice (MSCD1). Surface modifications of gold nanorods were achieved using optical spectroscopy (UV–VIS), electron microscopy (TEM), zeta-potential, and FTIR. Gold nanorods were incubated in MSCD1 in order to achieve a cellular uptake that was characterized by a transmission electron microscope (TEM). For photoacoustic imaging, Multi-Spectral Optoacoustic Tomography (MSOT) was used. The results demonstrated good cellular uptake for PEG–CALNN–TAT GNRs and the successful use of modified gold nanorods as both a contrast agent in photoacoustic imaging and as a novel tracking bioimaging technique. Full article
(This article belongs to the Special Issue Diagnostic Photoacoustic Imaging)
Show Figures

Figure 1

Back to TopTop